Evidence map›Paper›PMID 35305124›Full record

ArticleApplied microbiology and biotechnology2022

Mechanism of high D-aspartate production in the lactic acid bacterium Latilactobacillus sp. strain WDN19.

Kengo Kajitani, Takumi Ishikawa, Tomohiro Kobayashi, Miharu Asato, Kimihiko Shibata, Tomoaki Kouya, Shouji Takahashi

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Recent progress in microbial production of D-aspartate.World journal of microbiology & biotechnology · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Kengo KajitaniDepartment of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan.
Takumi IshikawaDepartment of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan.
Tomohiro KobayashiDepartment of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan.
Miharu AsatoDepartment of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan.
Kimihiko ShibataDepartment of Applied Chemistry and Biochemistry, National Institute of Technology, Fukushima College, Iwaki, Fukushima, 970-8034, Japan.
Tomoaki KouyaDepartment of Materials Chemistry and Bioengineering, National Institute of Technology, Oyama College, Tochigi, 323-0806, Japan.
Shouji TakahashiDepartment of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan. shoutaka@vos.nagaokaut.ac.jp.ORCID http://orcid.org/0000-0002-0279-9173
Nagaoka University of Technology · JPFukushima College · JPNagaoka University · JPNational Institute of Technology, Oyama College · JP

Funding

Japan Society for the Promotion of Science 19K05765
6 · The paper itself

Abstract

D-Aspartate (D-Asp) is a useful compound for a semisynthetic antibiotic and has potentially beneficial effects on humans. Several lactic acid bacteria (LAB) species produce D-Asp as a component of cell wall peptidoglycan. We previously isolated a LAB strain (named strain WDN19) that can extracellularly produce a large amount of D-Asp. Here, we show the factors that contribute to high D-Asp production ability. Strain WDN19 was most closely related to Latilactobacillus curvatus. The D-Asp production ability of strain WDN19 in a rich medium was 13.7-fold higher than that of L. curvatus DSM 20019. A major part of D-Asp was synthesized from L-Asp contained in the medium by aspartate racemase (RacD). During their cultivation, the RacD activity in strain WDN19 was higher than in strain DSM 20019, especially much higher in the early exponential growth phase because of the higher racD transcription and the higher activity of RacD itself of strain WDN19. In a synthetic medium, the extracellular production of D,L-Asp was observed in strain WDN19 but not in strain DSM 20019. The addition of L-asparagine (L-Asn) to the medium increased and gave D,L-Asp production in strains WDN19 and DSM 20019, respectively, suggesting L-Asp synthesis by L-asparaginase (AsnA). The L-Asn uptake ability of the strains was similar, but the AsnA activity in the middle exponential and early stationary growth phases and intracellular D,L-Asp was much higher in strain WDN19. In their genome sequences, only an aspartate aminotransferase gene was found among L-Asp-metabolizing enzymes, except for RacD, but was disrupted in strain WDN19 by transposon insertion. These observations indicated that the high D-Asp production ability of strain WDN19 was mainly based on high RacD and AnsA activities and L-Asp supply. KEY POINTS: • Strain WDN19 was suggested to be a strain of Latilactobacillus curvatus. • Extracellular high d-Asp production ability was not a common feature of L. curvatus. • High d-Asp production was due to high RacD and AnsA activities and l-Asp supply.

Indexed as

Aspartic AcidLactobacillalesAsparagineD-Aspartic AcidHumansLactic AcidLactobacillaceaeLactobacillusAsparagineAspartic AcidD-Aspartic AcidLactic AcidAsparaginaseAspartate racemaseD-AspartateLactic acid bacteriaL-AspartateLatilactobacillus curvatus

Identifiers

PMID35305124
OpenAlexW4220986063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.